Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: pathology

Department of Defense and VA Prepare to Pool Health Data

Laboratory Information Systems / By Robert Michel

IT’S ANOTHER IMPORTANT STEP on the road to a true “universal patient medical record.” Two government agencies are preparing to consolidate access to separate pools of healthcare data. Earlier this week, the Department of Defense (DoD) and the Department of Veterans Affairs (VA) announced two pilot projects that, for the first time, will allow physicians …

Department of Defense and VA Prepare to Pool Health Data Read More »

To access this post, you must purchase The Dark Report.

“April 26, 2004 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By R. Lewis Dark

Pathology gets another plug! CBS television recognized National Medical Laboratory Week with public service announcements (PSAs) featuring CSI: Crime Scene Investigation star William Peterson. The story behind the story is that Peterson asked CBS to cover production costs and broadcast time to allow him to say something about the laboratory staffing shortage and to salute …

“April 26, 2004 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Florida Issues State RFP For Sole Medicaid Lab

Managed Care Contracts / By Robert Michel

CEO SUMMARY: If competitive bidding for Medicare business is something universally viewed as bad by the laboratory industry, then the lab services RFP issued by Florida’s Medicaid program must be considered a serious threat to the status quo. Further, the fact that Medicaid officials in Florida designed a 28-day RFP process to award a single …

Florida Issues State RFP For Sole Medicaid Lab Read More »

To access this post, you must purchase The Dark Report.

LabCorp Buys MDS Labs In New York and Georgia

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: It’s the final chapter of the “Canadian Invasion” of the U.S. laboratory testing market. In the mid-1990s, both MDS and Dynacare built a sizeable presence in the United States as they both worked to develop joint ventures with hospital laboratories. Dynacare was acquired by LabCorp in 2002. In selling two U.S. lab operations, …

LabCorp Buys MDS Labs In New York and Georgia Read More »

To access this post, you must purchase The Dark Report.

Seattle Hospital Lab JVs Involve Quest & LabCorp

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: Joint ventures and collaborative business relationships between hospital laboratories and commercial laboratories continue to be a difficult business model. Recent events in Seattle demonstrate the challenges and frustrations of establishing such ventures, then making them successful. One footnote to the Seattle story is the success of a regional laboratory network at grabbing market …

Seattle Hospital Lab JVs Involve Quest & LabCorp Read More »

To access this post, you must purchase The Dark Report.

Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.

Clinical Laboratory Trends / By Robert Michel

EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per share to purchase all remaining shares of U.S. Oncology, Inc. which it …

Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc. Read More »

To access this post, you must purchase The Dark Report.

AmeriPath Reports on 2003, Its First Year as a Private Firm

Pathology Trends / By Robert Michel

WILL BUSINESS BE BETTER for AmeriPath, Inc. as a private company than it was as a publicly-traded firm? Its 2003 financial report indicates some interesting challenges, many common to all laboratories. First, a look at basic numbers. AmeriPath’s net revenues grew from $478.8 million in 2002 to $485.0 million in 2003. That’s a growth rate …

AmeriPath Reports on 2003, Its First Year as a Private Firm Read More »

To access this post, you must purchase The Dark Report.

“April 5, 2004 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

There’s a new national lab company ready to compete. This week American Esoterix Laboratories, Inc. (AEL) announced it was open and ready for business. Based in Brentwood, Tennessee, it has already completed two lab acquisitions (ThromboCare Laboratories and Viral Diagnostics, Inc., both in the Dallas, Texas area). Chairman and CEO is Brian Carr. President and …

“April 5, 2004 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Oncology Diagnostics Attracts Big Money

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition of IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the potential to send new ripples across the national market for oncology testing. What makes the Genzyme–IMPATH combination particularly fascinating was the $1 billion Genzyme paid, just …

Oncology Diagnostics Attracts Big Money Read More »

To access this post, you must purchase The Dark Report.

IMPATH Has a Buyer: Genzyme Pays $215 Mil

Anatomic Pathology / By Robert Michel

CEO SUMMARY: Two unexpected things happened in IMPATH’s Chapter 11 bankruptcy action. First, it attracted a buyer willing to pay the premium price of $215 million for its assets. Second, the buyer was not another laboratory company. Rather, it is a new entrant into the oncology diagnostics marketplace. This raises interesting questions as to Genzyme’s …

IMPATH Has a Buyer: Genzyme Pays $215 Mil Read More »

To access this post, you must purchase The Dark Report.

;